Baron, Frédéric http://orcid.org/0000-0002-2944-3812
Ruggeri, Annalisa http://orcid.org/0000-0002-7261-2765
Peczynski, Christophe http://orcid.org/0000-0002-3829-0088
Labopin, Myriam http://orcid.org/0000-0003-4514-4748
Bourhis, Jean-Henri
Michallet, Mauricette
Chevallier, Patrice http://orcid.org/0000-0003-3142-5581
Sanz, Jaime http://orcid.org/0000-0001-6934-4619
Forcade, Edouard http://orcid.org/0000-0002-8873-2868
Saccardi, Riccardo
Potter, Victoria
Gluckman, Eliane
Nagler, Arnon http://orcid.org/0000-0002-0763-1265
Mohty, Mohamad http://orcid.org/0000-0002-7264-808X
Funding for this research was provided by:
FB is Senior Research Associate at the National Fund for Scientific Research (FNRS) Belgium.
Article History
Received: 7 June 2022
Revised: 29 March 2023
Accepted: 21 April 2023
First Online: 10 May 2023
Competing interests
: FB has received travel grants and/or speaker honoraria from Celgene, Abbvie, Novartis, Pfizer and Sanofi. The other authors declare that they have no relevant conflict of interest.
: The scientific boards of the ALWP of the EBMT approved this study. The study was conducted according to the Declaration of Helsinki and Good Clinical Practice guidelines.